STEPS Trial - Spheramine Safety and Efficacy Study - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00206687

Locations


United States, Alabama

	Birmingham, Alabama, United States, 35294

United States, California

	Los Angeles, California, United States, 90095

United States, Florida

	Tampa, Florida, United States, 33606

United States, Georgia

	Atlanta, Georgia, United States, 30322

United States, Illinois

	Chicago, Illinois, United States, 60612

United States, Kansas

	Kansas City, Kansas, United States, 66160

United States, Massachusetts

	Boston, Massachusetts, United States, 02118-2394

United States, New York

	New York, New York, United States, 10029

United States, Pennsylvania

	Philadelphia, Pennsylvania, United States, 19104

United States, Texas

	Houston, Texas, United States, 77030

Germany, Hamburg / 287

	Hamburg, Hamburg / 287, Germany, 22307

Germany, Hessen / 307

	Marburg, Hessen / 307, Germany, 35043

Germany, Saarland / 305

	Homburg, Saarland / 305, Germany, 66421

Germany, Sachsen / 313

	Dresden, Sachsen / 313, Germany, 01307

Spain

	Barcelona, Spain, 08036

Sponsors and Collaborators

Bayer

Titan Pharmaceuticals

Investigators


Study Director:	Bayer Study Director	Bayer